All News
Filter News
Found 808,539 articles
-
Myovant Announces Presentation Of Positive Phase II Data For Relugolix In Women With Heavy Menstrual Bleeding And Uterine Fibroids At The Annual Meeting Of The American Congress Of Obstetricians And Gynecologists
5/8/2017
-
Oncolytics Biotech Announces FDA Fast Track Designation For REOLYSIN In Metastatic Breast Cancer
5/8/2017
-
Horizon Pharma Pays $145 Million For River Vision And Its Rare Eye Disease Drug
5/8/2017
-
Conspiracy Theory: Did Puma Biotech Exec Resign Because of Bad News Ahead?
5/8/2017
-
Faron Pharmaceuticals Ltd. Release: Update On Interest Phase III Study For Traumakine In Ards From IDMC
5/8/2017
-
Agile Therapeutics, Inc. Reports Additional Phase III SECURE Study Results Relating To Twirla At ACOG 2017
5/8/2017
-
Intra-Cellular Therapies Presents Data Supporting The Potential For Potent And Rapid Antidepressant Activity With Lumateperone
5/8/2017
-
Araim Pharmaeuticals' Cibinetide (ARA 290) Regenerates Small Nerve Fibers And Improves Neuropathic Clinical Symptoms In The Orphan Disease Of Sarcoidosis
5/8/2017
-
Ocular Therapeutix Presents Additional Phase III Data And Patient Reported Outcomes Results For DEXTENZA At American Society of Cataract & Refractive Surgery Symposium
5/8/2017
-
NovoCure Release: Combination Of Optune With Standard Of Care Chemotherapy, Temozolomide, Delayed Decline In Several Health-Related Quality Of Life Scales Compared To Temozolomide Alone For Newly Diagnosed Glioblastoma Patients
5/8/2017
-
Rasna Therapeutics Advances Development Of A Novel Treatment For NPM1-Mutated Acute Myeloid Leukemia
5/8/2017
-
Takeda Announces Publication Of ALUNBRIG (brigatinib) Pivotal Phase II ALTA Clinical Trial Data In Journal Of Clinical Oncology
5/8/2017
-
AGP Therapeutics, LLC Release: Tau Immunotherapy Shows Great Potential In Pre-Clinical Studies
5/8/2017
-
Syros Pharma Presents New Insights On Mechanism Of Action Of SY-1425, Its First-In-Class Selective RARa Agonist, In Oral Plenary Session At AACR Hematologic Malignancies Conferencee
5/8/2017
-
Botanix Commences First Clinical Study For BTX 1503
5/8/2017
-
Embera NeuroTherapeutics, Inc. Announces Positive Topline Data From Phase Ib Cocaine Interaction Study Of EMB-001
5/8/2017
-
Gray Death: The Most Powerful New Opioid Combo That's Risky Even To Touch
5/8/2017
-
Nymox Files For Approval Of First In Class Prostate Drug In Europe: Company To Hold Teleconference Wednesday May 10 At 4:30 EDT
5/8/2017
-
Paratek Pharma Announces Completion Of Enrollment For Oral-Only Omadacycline Phase III Skin Study, Top-Line Data Expected In Mid-July
5/8/2017
-
Axsome Receives FDA Fast Track Designation For AXS-05 For Alzheimer’s Disease Agitation
5/8/2017